QR-koodi

Promotion of colorectal cancer cell death by ezetimibe via mTOR signaling-dependent mitochondrial dysfunction

Introduction: Colorectal cancer (CRC) is the fourth most common cancer worldwide, with high morbidity and mortality rates. In recent years, high-fat diet has been shown to increase CRC morbidity, highlighting the possibility of the application of hypolipidemic drugs for CRC treatment. In this study,...

Täydet tiedot

Tallennettuna:
Päätekijät: Yuanyuan Zheng, Wenjuan Yang, Yewei Jia, Jie Ji, Liwei Wu, Jiao Feng, Yan Li, Ziqi Cheng, Jie Zhang, Jingjing Li, Weiqi Dai, Xuanfu Xu, Jianye Wu, Yingqun Zhou, Chuanyong Guo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2023-02-01
Sarja:Frontiers in Pharmacology
Aiheet:
colorectal cancer
cell death
ezetimibe
MTOR signaling
mitochondrial dysfunction
Linkit:https://www.frontiersin.org/articles/10.3389/fphar.2023.1081980/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia